PLUNKETT'S BIOTECH, PHARMACEUTICALS & GENETICS INDUSTRY ALMANAC 2023
Key Findings:
A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry. Gain vital insights that can help shape strategy for business development, product development and investments.
Key Features:
- Business trends analysis
- In-depth industry overview
- Technology trends analysis
- Forecasts
- Spending, investment, and consumption discussions
- In-depth industry statistics and metrics
- Industry employment numbers
Industry Glossary
Industry Contacts list, including Professional Societies and Industry Associations
Profiles of industry-leading companies
- U.S. and Global Firms
- Publicly held, Private and Subsidiaries
- Executive Contacts
- Revenues
- For Public Companies: Detailed Financial Summaries
Statistical Tables Provided: 8
Companies Profiled: 400
Geographic Focus: Global
Key Questions Answered Include:
- How is the industry evolving?
- How is the industry being shaped by new technologies?
- How is demand growing in emerging markets and mature economies?
- What is the size of the market now and in the future?
- What are the financial results of the leading companies?
- What are the names and titles of top executives?
- What are the top companies and what are their revenues?
Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry
1. The State of the Biotechnology Industry Today
2. The Coronavirus’ Effect on the Biotech, Pharmaceuticals & Genetics Industry
3. A Short History of Biotechnology
4. Fast Track Drugs Come to Market in the U.S. with FDA Cooperation
5. Ethanol Production Soared, But U.S. Federal Subsidy Expires
6. Cellulosic Ethanol Makes Slow Commercial Progress
7. Major Drug Companies Acquire or Partner With Smaller Biotech Firms
8. Pharmaceutical R&D Improves with Artificial Intelligence (AI)
9. From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
10. Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
11. Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
12. Vaccines & Viruses as Therapies/mRNA Shows Great Promise
13. Massive R&D Investment Required for Development and Approval of New Drug/Drug Prices Soar
14. Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues
15. America Pays Higher Prices for Drugs Than Other Nations/U.S. Government Launches Drug Price Negotiation and Control Powers for Medicare
16. Biotech and Orphan Drugs Create New Revenues for Drug Firms
17. Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/ Competition Will Be Fierce
18. Market for CBD Is on the Rise
19. Stem Cells and 3-D Printing—A New Era of Tissue Replacement Takes Shape
20. Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High
21. Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation
22. Plant-Based Meat Substitutes Developed
23. Selective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds
24. Immunotherapy and CAR-T Create Exciting New Approach to Fighting Cancers
25. Technology Discussion—Genes and DNA
26. Technology Discussion—Proteins and Proteomics
27. Technology Discussion—DNA Chips
28. Technology Discussion—SNPs (“Snips”)
29. Technology Discussion—Synthetic Biology
30. Technology Discussion—Recombinant DNA
31. Technology Discussion—Polymerase Chain Reaction (PCR)
Biotech, Pharmaceuticals & Genetics Industry Statistics
1. Biotech Industry Statistics and Market Size Overview
2. The U.S. Drug Discovery & Approval Process
3. U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2021
4. Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2021
5. Federal R&D & R&D Plant Funding for Basic Research, U.S.: Fiscal Years 2021-2023
6. U.S. Exports & Imports of Pharmaceutical Products: 2016-2021
7. Prescription Drug Expenditures, U.S.: Selected Years, 2014-2030
8. NSF Budget by Appropriation (Dollars in Millions), Fiscal Years 2021-2023
- Introduction
- How to Use This Book
- Chapter 1: Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry
- 1) The State of the Biotechnology Industry Today
- 2) The Coronavirus’ Effect on the Biotech, Pharmaceuticals & Genetics Industry
- 3) A Short History of Biotechnology
- 4) Fast Track Drugs Come to Market in the U.S. with FDA Cooperation
- 5) Ethanol Production Soared, But U.S. Federal Subsidy Expires
- 6) Cellulosic Ethanol Makes Slow Commercial Progress
- 7) Major Drug Companies Acquire or Partner With Smaller Biotech Firms
- 8) Pharmaceutical R&D Improves with Artificial Intelligence (AI)
- 9) From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
- 10) Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
- 11) Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
- 12) Vaccines & Viruses as Therapies/mRNA Shows Great Promise
- 13) Massive R&D Investment Required for Development and Approval of New Drug/Drug Prices Soar
- 14) Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues
- 15) America Pays Higher Prices for Drugs Than Other Nations/U.S. Government Launches Drug Price Negotiation and Control Powers for Medicare
- 16) Biotech and Orphan Drugs Create New Revenues for Drug Firms
- 17) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/ Competition Will Be Fierce
- 18) Market for CBD Is on the Rise
- 19) Stem Cells and 3-D Printing—A New Era of Tissue Replacement Takes Shape
- 20) Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High
- 21) Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation
- 22) Plant-Based Meat Substitutes Developed
- 23) Selective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds
- 24) Immunotherapy and CAR-T Create Exciting New Approach to Fighting Cancers
- 25) Technology Discussion—Genes and DNA
- 26) Technology Discussion—Proteins and Proteomics
- 27) Technology Discussion—DNA Chips
- 28) Technology Discussion—SNPs (“Snips”)
- 29) Technology Discussion—Synthetic Biology
- 30) Technology Discussion—Recombinant DNA
- 31) Technology Discussion—Polymerase Chain Reaction (PCR)
- Chapter 2: Biotech, Pharmaceuticals & Genetics Industry Statistics
- Biotech Industry Statistics and Market Size Overview
- The U.S. Drug Discovery & Approval Process
- U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2021
- Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2021
- Federal R&D & R&D Plant Funding for Basic Research, U.S.: Fiscal Years 2021-2023
- U.S. Exports & Imports of Pharmaceutical Products: 2016-2021
- Prescription Drug Expenditures, U.S.: Selected Years, 2014-2030
- NSF Budget by Appropriation (Dollars in Millions), Fiscal Years 2021-2023
- Chapter 3: Important Biotech, Pharmaceuticals & Genetics Industry Contacts
- (Addresses, Phone Numbers and Internet Sites)
- Chapter 4: THE BIOTECH 400:
- Who They Are and How They Were Chosen
- Index of Companies Within Industry Groups
- Alphabetical Index
- Index of U.S. Headquarters Location by State
- Index of Non-U.S. Headquarters Location by Country
- Individual Profiles on Each of THE BIOTECH 400
- Additional Indexes
- Index of Hot Spots for Advancement for Women/Minorities
- Index by Subsidiaries, Brand Names and Selected Affiliations
- A Short Biotech, Pharmaceuticals & Genetics Industry Glossary
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook